Role of the tumor microenvironment in CLL pathogenesis
Chronic lymphocytic leukemia (CLL) cells extensively interact with and depend on their
surrounding tumor microenvironment (TME). The TME encompasses a heterogeneous array …
surrounding tumor microenvironment (TME). The TME encompasses a heterogeneous array …
Richter Transformation of Chronic Lymphocytic Leukemia—Are We Making Progress?
HY Audil, SR Kosydar, DP Larson… - Current Hematologic …, 2023 - Springer
Abstract Purpose of Review The treatment paradigm of chronic lymphocytic leukemia (CLL)
has dramatically changed with the advent of novel targeted agents over the past decade …
has dramatically changed with the advent of novel targeted agents over the past decade …
Update on management of diffuse large B-cell lymphoma Richter's transformation
O Sośnia, B Puła - Acta Haematologica Polonica, 2024 - journals.viamedica.pl
Richter's transformation (RT) is defined as the development of an aggressive lymphoma in 2–
10% of patients with chronic lymphocytic leukemia (CLL). Despite significant advances in …
10% of patients with chronic lymphocytic leukemia (CLL). Despite significant advances in …
[HTML][HTML] Management of Richter Transformation
MMP Home - Management, 2023 - hematologyandoncology.net
MD Transformation of CLL into aggressive lymphoma, known as Richter transformation (RT),
is relatively uncommon. During the chemotherapy era of CLL treatment, the rate of RT in …
is relatively uncommon. During the chemotherapy era of CLL treatment, the rate of RT in …
[PDF][PDF] Mesto alogenske presaditve pri kronični limfocitni levkemiji v obdobju novih zdravil
P Novak, A Bošković - Zbornik povzetkov oktober 2023 - zbornica-zveza.si
Zdravljenje kronične limfocitne levkemije (KLL) je v zadnjem desetletju s prihodom novih
zdravil doživelo preporod. Majhne tarčne molekule, in sicer zaviralci Brutonove tirozin …
zdravil doživelo preporod. Majhne tarčne molekule, in sicer zaviralci Brutonove tirozin …
Využití imunoterapie a cílené léčby u Richterovy transformace
T Líkařová, M Špaček - Onkologie, 2023 - onkologiecs.cz
Richterův syndrom (RS) je závažnou komplikací chronické lymfocytární leukemie, která se
ročně vyskytuje ve 2-10% případů. I přes nové modality léčby na poli hematoonkologie …
ročně vyskytuje ve 2-10% případů. I přes nové modality léčby na poli hematoonkologie …